Meilleure Health International Industry Group (HKSE:02327) Days Sales Outstanding : 251.93 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Meilleure Health International Industry Group Days Sales Outstanding?

Meilleure Health International Industry Group's average Accounts Receivable for the six months ended in Dec. 2023 was HK$75.2 Mil. Meilleure Health International Industry Group's Revenue for the six months ended in Dec. 2023 was HK$54.5 Mil. Hence, Meilleure Health International Industry Group's Days Sales Outstanding for the six months ended in Dec. 2023 was 251.93.

The historical rank and industry rank for Meilleure Health International Industry Group's Days Sales Outstanding or its related term are showing as below:

HKSE:02327' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28 Med: 158.55 Max: 293.68
Current: 236.86

During the past 13 years, Meilleure Health International Industry Group's highest Days Sales Outstanding was 293.68. The lowest was 42.28. And the median was 158.55.

HKSE:02327's Days Sales Outstanding is ranked worse than
92.17% of 498 companies
in the Conglomerates industry
Industry Median: 60.925 vs HKSE:02327: 236.86

Meilleure Health International Industry Group's Days Sales Outstanding declined from Dec. 2022 (315.83) to Dec. 2023 (251.93).

Meilleure Health International Industry Group Days Sales Outstanding Historical Data

The historical data trend for Meilleure Health International Industry Group's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meilleure Health International Industry Group Days Sales Outstanding Chart

Meilleure Health International Industry Group Annual Data

Trend

Mar14

Mar15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

169.77

115.54

111.62

293.68

286.36

Meilleure Health International Industry Group Semi-Annual Data
	Mar14	Sep14	Mar15	Sep15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															171.62	256.40	315.83	183.13	251.93

Competitive Comparison of Meilleure Health International Industry Group's Days Sales Outstanding

For the Conglomerates subindustry, Meilleure Health International Industry Group's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Meilleure Health International Industry Group's Days Sales Outstanding Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Meilleure Health International Industry Group's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Meilleure Health International Industry Group's Days Sales Outstanding falls into.

Meilleure Health International Industry Group Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Meilleure Health International Industry Group's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (101.354	+	101.533)	/	2 )	/	129.304	*	365
=	101.4435					/	129.304	*	365
=	286.36

Meilleure Health International Industry Group's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (48.842	+	101.533)	/	2 )	/	54.466	*	365 / 2
=	75.1875					/	54.466	*	365 / 2
=	251.93

Meilleure Health International Industry Group (HKSE:02327) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Meilleure Health International Industry Group Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Meilleure Health International Industry Group's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Meilleure Health International Industry Group (HKSE:02327) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Meilleure Health International Industry Group Ltd (HKSE:02327) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

89 Queensway, Unit 2906, Tower 1, Lippo Centre, Admiralty, Hong Kong, HKG

Website

http://www.meilleure.com.cn

Meilleure Health International Industry Group Ltd is an investment holding company principally engaged in the trading of healthcare products, chemical materials, and building materials. The company's operating segment includes Trading business; Agency service; Property development; Property investment and leasing; Healthcare related business and Industrial hemp business. The Trading business segment includes the trading of construction materials. Geographically, it derives a majority of revenue from PRC.

Executives

Shunda Investment Limited	2201 Interest of corporation controlled by you
Zhongjia U-home Investment Limited	2101 Beneficial owner
Zhou Xuzhou	2201 Interest of corporation controlled by you
Haitong Ut Leasing Hk Limited	2106 Person having a security interest in shares
U-home Group International Ltd
Haitong International Finance Company Limited

Meilleure Health International Industry Group (HKSE:02327) Headlines

No Headlines